Evidence map›Paper›PMID 40901573›Full record

ArticleInternational journal of chronic obstructive pulmonary disease2025

The Humanistic and Economic Burden of COPD Patients in Urban China: A Propensity Score Matching Study.

Lei Dou, Yu Zheng, Junchao Feng, Zhezhou Huang, Fei Qin, Mingyue Gao, Shunping Li

Abstract read
In one paragraph

Article in International journal of chronic obstructive pulmonary disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Lei DouDepartment of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China.ORCID 0000-0002-8457-0224
Yu ZhengBlood Center of Shandong Province, Jinan, Shandong, People's Republic of China.
Junchao FengDepartment of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China.
Zhezhou HuangCerner Enviza, Shanghai, People's Republic of China.
Fei QinCerner Enviza, Shanghai, People's Republic of China.
Mingyue GaoCerner Enviza, Shanghai, People's Republic of China.ORCID 0009-0007-4366-4594
Shunping LiDepartment of Social Medicine and Health Management, School of Public Health, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, People's Republic of China.ORCID 0000-0001-8144-6220

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Chronic obstructive pulmonary disease (COPD) is a leading cause of death in China. However, few national surveys have comprehensively evaluated the health and economic outcomes among COPD patients in China. The objective of this study was to examine and compare the humanistic and economic burden of COPD patients with a control group. Patients and Methods: Data from the 2020 National Health and Wellness Survey (NHWS) in China (N=20051), a nationally representative survey targeting urban adults, was used in this study. The propensity score matching (PSM) method was employed to match respondents who reported being diagnosed with COPD by a physician with those who did not have COPD. Differences between COPD patients and matched controls were assessed in terms of quality of life (using EQ-5D-5L and SF-12v2), work productivity loss, healthcare resource utilization over the past 6 months, and estimated annual indirect costs. Results: COPD patients exhibited significantly worse outcomes compared to non-COPD respondents. The mean scores for MCS, PCS, and health state utility (HSU) were substantially lower in COPD patients than in the control group (47.69 vs 49.49, 47.27 vs 51.71, and 0.90 vs 0.94, respectively; all P <0.01). Moreover, the score difference between COPD patients and the control group reached minimal clinically important difference (MCID) for both PCS and HSU. Compared to the non-COPD population, COPD patients reported higher rates of absenteeism (6.88% vs 3.74%, P<0.01), presenteeism (28.02% vs 21.43%, P<0.01), work productivity loss (31.31% vs 23.57%, P<0.01) and activity impairment (27.15% vs 19.53%, P<0.01), resulting in greater indirect cost. The number of hospitalizations was significantly higher among COPD patients than the non-COPD population (2.11 vs 1.96, P<0.01), while the number of outpatient visits was similar to that of the control group. Conclusion: These findings highlight the pervasive impact of COPD on health outcomes. The results highlight the substantial burden of COPD compared with the non-COPD population, suggesting that increased attention and targeted interventions are warranted to address the significant health and economic challenges posed by this disease.

Indexed as

Cost of IllnessHealth Care CostsPulmonary Disease, Chronic ObstructiveUrban HealthAbsenteeismAdultAgedCase-Control StudiesChinaCross-Sectional StudiesEfficiencyFemaleFunctional StatusHealth StatusHealth SurveysHumanschronic obstructive pulmonary diseasedisease costshealthcare resource usehealth-related quality of lifework productivity loss

Identifiers

PMID40901573
PMCPMC12400111

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.